Basal biomarkers Nestin and INPP4b accurately identify intrinsic breast cancer subtype and predict benefit from anthracycline vs. non-anthracycline based treatment in the CCTG MA. 5 phase III randomized clinical trial

作者： Karama Asleh , Dongxia Gao , Dongsheng Tu , Lois Shepherd , Mark N Levine

DOI:

关键词: